MENU

ELEV Elevation Oncology Forecast, Technical & Fundamental Analysis

Industry Biotechnology
ELEV
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
ELEV
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ELEV is expected to report earnings to rise 25.28% to -22 cents per share on October 31

Elevation Oncology ELEV Stock Earnings Reports
Q3'24
Est.
$-0.23
Q2'24
Beat
by $0.04
Q1'24
Missed
by $0.03
Q4'23
Beat
by $0.04
Q3'23
Beat
by $0.06
The last earnings report on August 06 showed earnings per share of -18 cents, beating the estimate of -21 cents. With 980.32K shares outstanding, the current market capitalization sits at 34.87M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
101 Federal Street
Phone
+1 716 371-1125
Employees
29
Web
https://www.elevationoncology.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME23.14-0.28
-1.20%
GameStop Corp
TSLA210.60-3.51
-1.64%
Tesla
SPY552.08-11.60
-2.06%
SPDR® S&P 500® ETF Trust
AAPL222.77-6.23
-2.72%
Apple
BTC.X57431.023000-1681.457000
-2.84%
Bitcoin cryptocurrency

ELEV and Stocks

Correlation & Price change

A.I.dvisor tells us that ELEV and NKTX have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ELEV and NKTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELEV
1D Price
Change %
ELEV100%
-5.89%
NKTX - ELEV
29%
Poorly correlated
-3.01%
ARDX - ELEV
29%
Poorly correlated
-8.90%
PYPD - ELEV
28%
Poorly correlated
N/A
IMNM - ELEV
28%
Poorly correlated
-7.51%
YMAB - ELEV
27%
Poorly correlated
-3.00%
More